Search for Clinical Trial Results
Enteropathy-Associated T-Cell Lymphoma - 18 Studies Found
Status | Study |
Completed |
Study Name: Study of MLN8237 in Participants With Advanced Hematological Malignancies Condition:
|
Completed |
Study Name: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma Condition:
Date: 2009-05-11 Interventions: Drug: panobinostat and bortezomib oral panobinostat 30 mg 3 times per week AND intravenous bortezomib 1. |
Recruiting |
Study Name: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma Condition:
|
Recruiting |
Study Name: MAgnetic Resonance Imaging in COeliac Disease Condition:
Interventions: Other: Gluten free diet Patients will follow a gluten free diet |
Terminated |
Study Name: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Condition:
Date: 2008-05-02 Interventions:
|
Terminated |
Study Name: Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma Condition: Lymphoma Date: 2008-12-16 Interventions:
|
Completed |
Study Name: SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma Condition: Lymphoma Date: 2008-11-06 Interventions:
|